These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17343427)

  • 21. Veterinary pharmacovigilance in India: A need of hour.
    Kumar R; Kalaiselvan V; Verma R; Kaur I; Kumar P; Singh GN
    Indian J Pharmacol; 2017; 49(1):2-3. PubMed ID: 28458414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a new categorization system for pesticides exposure to support harmonized reporting between EU Member States.
    Settimi L; Orford R; Davanzo F; Hague C; Desel H; Pelclova D; Dragelyte G; Mathieu-Nolf M; Adams R; Duarte-Davidson R
    Environ Int; 2016 May; 91():332-40. PubMed ID: 27016706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An overview of spontaneous reporting of adverse drug reactions (ARDs) in Zimbabwe.
    Ball D
    Cent Afr J Med; 2000 Jan; 46(1):23-4. PubMed ID: 14674204
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods.
    Montastruc JL; Sommet A; Lacroix I; Olivier P; Durrieu G; Damase-Michel C; Lapeyre-Mestre M; Bagheri H
    Joint Bone Spine; 2006 Dec; 73(6):629-32. PubMed ID: 17110152
    [No Abstract]   [Full Text] [Related]  

  • 25. Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems.
    Kessler DA
    JAMA; 1993 Jun; 269(21):2765-8. PubMed ID: 8492403
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of adverse treatment effects in controlled trials.
    Lièvre M
    Joint Bone Spine; 2006 Dec; 73(6):624-6. PubMed ID: 17113807
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacogenomic profiling in postmarketing surveillance: prospects and challenges.
    Issa AM
    Pharmacogenomics; 2003 Sep; 4(5):647-55. PubMed ID: 12943471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Farmacovigilance: the way towards a safer drug use].
    Dobrić S
    Vojnosanit Pregl; 2007 Apr; 64(4):229-30. PubMed ID: 17580530
    [No Abstract]   [Full Text] [Related]  

  • 29. Postmarketing surveillance for drug abuse.
    Arfken CL; Cicero TJ
    Drug Alcohol Depend; 2003 Jun; 70(3 Suppl):S97-105. PubMed ID: 12759200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The epidemiology of preventable adverse drug events: a review of the literature.
    von Laue NC; Schwappach DL; Koeck CM
    Wien Klin Wochenschr; 2003 Jul; 115(12):407-15. PubMed ID: 12918183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse drug reactions and therapeutic errors in older adults: a hazard factor analysis of poison center data.
    Cobaugh DJ; Krenzelok EP
    Am J Health Syst Pharm; 2006 Nov; 63(22):2228-34. PubMed ID: 17090743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A clinicians' guide to adverse drug reactions.
    Ranganathan SS; Fernandopulle R
    Ceylon Med J; 2007 Jun; 52(2):41-4. PubMed ID: 17691557
    [No Abstract]   [Full Text] [Related]  

  • 33. The prescription drug user fee act: active postmarketing drug surveillance and safety.
    Lyles A
    Clin Ther; 2002 May; 24(5):800-2. PubMed ID: 12075947
    [No Abstract]   [Full Text] [Related]  

  • 34. Involving the patient in reporting adverse drug reactions.
    Campbell JP; Howie JG
    J R Coll Gen Pract; 1988 Aug; 38(313):370-1. PubMed ID: 3256650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postmarketing surveillance of adverse reactions to drugs.
    Rawlins MD
    Br Med J (Clin Res Ed); 1984 Mar; 288(6421):879-80. PubMed ID: 6423125
    [No Abstract]   [Full Text] [Related]  

  • 36. Postmarketing surveillance of adverse reactions to drugs.
    Inman WHW
    Br Med J (Clin Res Ed); 1984 Apr; 288(6424):1155-6. PubMed ID: 6424767
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug makers' adverse event reports are often incomplete, US report finds.
    McCarthy M
    BMJ; 2015 Feb; 350():h651. PubMed ID: 25652561
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug-related risks.
    Klotz U
    Eur J Clin Pharmacol; 2007 Nov; 63(11):983-4. PubMed ID: 17882407
    [No Abstract]   [Full Text] [Related]  

  • 39. The epidemiology and type of medication errors reported to the National Poisons Information Centre of Ireland.
    Cassidy N; Duggan E; Williams DJ; Tracey JA
    Clin Toxicol (Phila); 2011 Jul; 49(6):485-91. PubMed ID: 21824059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two UK Government proposals bearing on drug safety.
    Griffin JP
    Adverse Drug React Toxicol Rev; 1997 Mar; 16(1):1-7. PubMed ID: 9192053
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.